15 , e1007889 (2019)
Trujillo, J.M., Nuffer, W., and Smith, B.A
A recent study has proposed a set of eight FIRLs tags, namely AC138904.1, AP005205.2, AC007114.1, LINC00665, UBXN10-AS1 AC083880.1, LINC01558, and AL023583.1, which may serve as a useful tool for guiding the prognosis and treatment decisions of ovarian cancer patients (Yang et al., 2023)
Researchers use cagrilintide as a tool compound because it extends amylin-like signaling at receptors in the calcitonin family
Moreover, managing diabetes during cancer treatment is a crucial aspect often overshadowed by the primary focus on cancer therapies
The study, International coverage of GLP-1 Receptor Agonists: A Review and Ethical Analysis of Discordant Approaches, was published on August 16, 2024 in the Lancet